As of November 14, 2026, KORU Medical Systems, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on March 16, 2026 (Form 8-K, March 16, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like KORU Medical Systems, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
KORU Medical Systems, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-03-16. Every row below is cited to the filing it comes from, and this page adds each new change as KORU Medical Systems, Inc. files it.
Also on the record for KORU Medical Systems, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| July 29, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.6% of the class | 5%+ stakes | Source |
| April 27, 2026 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 4.9% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Mathew P. Arens | 8.27% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13D/A, by Horton Capital Partners, LLC | 12.62% of the class | 5%+ stakes | Source |
| February 13, 2026 | Stake report, Schedule 13G/A, by Topline Capital Management, LLC | 8.5% of the class | 5%+ stakes | Source |
| January 21, 2026 | Stake report, Schedule 13G, by BlackRock, Inc. | 5.1% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs KORU Medical Systems, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on KORU Medical Systems, Inc. and the records around it.
KORU Medical Systems, Inc. elsewhere on the record
- 5%+ stake filings Jul 2026
- Who owns it
Companies that share a holder
- Horton Capital Partners Fund, LP also filed stake reports on 1 other company: Myomo, Inc. (May 2026)
- First Light Asset Management, LLC also filed stake reports on 12 other companies: NeuroPace Inc (Sep 2026), Neogenomics, Inc. (Aug 2026), PALVELLA THERAPEUTICS, INC. (Aug 2026)
- Topline Capital Management, LLC also filed stake reports on 13 other companies: AMERICAN VANGUARD CORP (Feb 2026), GREEN DOT CORP (Feb 2026), Sprout Social, Inc. (Feb 2026)
Watch KORU Medical Systems, Inc.
Get an email when KORU Medical Systems, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on KORU Medical Systems, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on KORU Medical Systems, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on KORU Medical Systems, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
7 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-03-16 | Reported | not named in the filing | 8-K, 2026-03-16 |
New leaders reset buying decisions — get the Full Report on KORU Medical Systems, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at KORU Medical Systems, Inc., with the record behind each one.
Find candidates like senior executive at KORU Medical Systems, Inc.Every change, in the filing's words
Reported
Linda Tharby, President and Chief Executive Officer of KORU Medical Systems, Inc. (the "Company"), has announced her retirement as Chief Executive Officer effective June 30, 2026 (the "Transition Date").
- Mr. Kalbermatten has been appointed to replace Ms. Tharby as the Company's President effective March 15, 2026 and will succeed Ms. Tharby as Chief Executive Officer effective July 1, 2026.
- In order to facilitate an orderly transition, on March 12, 2026, the Company and Ms. Tharby entered into a separation and transition agreement and general release approved by the Board (the "Transition Agreement") pursuant to which Ms. Tharby will continue to serve as a non-executive advisory employee following her retirement through December 31, 2026 (the "Advisory Period").
- Under the Transition Agreement, Ms. Tharby may only be terminated during the Advisory Period for "Cause," as defined in her Employment Agreement.
- Ms. Tharby will continue to serve on the Board through December 31, 2026 and will resign from the Board effective as of that date.
- Pursuant to the Transition Agreement, Ms. Tharby will receive regular base salary through the Transition Date, a 2025 bonus at a 100% payout percentage pursuant to the Company's Annual Incentive Compensation Plan ("AICP") with the stock portion fully vested as of March 15, 2026, and a 2026 AICP bonus prorated solely for service through the Transition Date at the final Company payout percentage with the stock portion fully vested as of March 15, 2027.
Tools for this story
Each opens in a new tab, filled in for KORU Medical Systems, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
